MedPath

Management of Postoperative Pain After Total Knee Replacement.

Phase 4
Completed
Conditions
Knee Replacement Arthroplasty
Postoperative Pain
Interventions
Drug: Periarticular Injection
Drug: Nerve Block
Registration Number
NCT01163214
Lead Sponsor
Mark J. Spangehl, M.D.
Brief Summary

The purpose of this study is to compare two methods of postoperative pain management in patients undergoing total knee replacement.

Detailed Description

Patients undergoing total knee replacement will be assigned at random to receive one of two methods of postoperative pain management. Patients assigned to nerve block will receive regional anesthetic nerve block using an indwelling femoral nerve catheter and a single shot sciatic nerve block. Patients assigned to periarticular injection will receive periarticular local injection into the periarticular soft tissues at the time of knee replacement using a combination of ropivacaine, epinephrine, ketorolac, and morphine sulphate. Additionally, all patients will be given a standardized combination of oral analgesic medications preoperatively and postoperatively. All patients will receive a posterior stabilized total knee replacement through an medial parapatellar approach.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
160
Inclusion Criteria
  • Unilateral primary total knee replacement.
  • Weight 50-125 kg.
  • Age 18-79 years.
  • Intact neurological exam to the surgical lower extremity.
  • Cognitively intact with ability to sign informed consent.
Exclusion Criteria
  • Renal insufficiency with creatinine >1.5 mg/dL.
  • Allergy to medication used in the study.
  • Using narcotic medication prior to surgery (morphine equivalents >=20 mg/day for >7 days.)
  • Prior open knee surgery with regional anesthesia or periarticular injection for post-operative pain management.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Periarticular InjectionPeriarticular InjectionInjection combination prior to skin closure.
Nerve BlockNerve BlockPreoperative femoral block with indwelling femoral catheter and a single shot sciatic block.
Primary Outcome Measures
NameTimeMethod
Post-Operative PainAfternoon on post-operative Day 1, approximately 14:00

Pain was measured using a linear analog scale for pain, with a scale from 0 (no pain) to 10 points (worst possible pain).

Secondary Outcome Measures
NameTimeMethod
Pain Scores in the Per-protocol Subset (Participants Who Received the Allocated Treatment)Afternoon on post-operative Day 1, approximately 14:00

Pain was measured using a linear analog scale for pain, with a scale from 0 (no pain) to 10 points (worst possible pain).

Narcotic UseIntraoperative, Day of surgery, Post-Operative Day 1, Post-Operative Day 2

Use of additional narcotic medications (as needed), measured in morphine equivalents.

Straight-leg RaiseDay 1 morning (AM), Day 1 afternoon (PM), Day 2 morning, Day 2 afternoon

Post-operative quadriceps function was measured by the number of participants who could perform a straight-leg raise.

Length of Stay in HospitalApproximately 2 days after surgery

Length of stay data were calculated from the medical record.

Number of Subjects Who Experienced Neurological Changes Postoperatively6 weeks postoperative

Participants were questioned at the 6 weeks follow-up visit regarding any neurological changes that were not present preoperatively.

Trial Locations

Locations (1)

Mayo Clinic

🇺🇸

Phoenix, Arizona, United States

© Copyright 2025. All Rights Reserved by MedPath